Gonzalo Recondo
11PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Feb 06, 2025
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.Maritza Ramos-Ramírez, Enrique Caballe-Pérez, José Lucio-Lozada
|Apr 24, 2023
Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer.Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti
|Apr 25, 2022
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S.Juan Bautista Blaquier, Gonzalo Recondo
|Jan 07, 2022
EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).Andrés F Cardona, Camila Ordóñez-Reyes, Alejandro Ruiz-Patiño
|Sep 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.Gonzalo Recondo, Linda Mahjoubi, Aline Maillard
|Aug 14, 2020
Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer.Gonzalo Recondo, Laura Mezquita
Pageof 2
Frequent Collaborators
3 joint publications
Biagio Ricciuti
2 joint publications
Juan Bautista Blaquier
2 joint publications
Oscar Arrieta
2 joint publications
Jianwei Che
2 joint publications
Giuseppe Lamberti
2 joint publications
Andrés Felipe Cardona
2 joint publications
Laura Mezquita
1 joint publications
Jean Paul Thiery
1 joint publications
Dariia Samofalova
1 joint publications
Lambros Tselikas
